MCT1 Inhibitor AZD3965 Increases Mitochondrial Metabolism, Facilitating Combination Therapy and Noninvasive Magnetic Resonance Spectroscopy

Mounia Beloueche‐Babari, Slawomir Wantuch, Teresa Casals Galobart, +7

Cancer Research

Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration

Mounia Beloueche‐Babari, Teresa Casals Galobart, Teresa Delgado‐Goñi, +5

British Journal of Cancer

The BRAF Inhibitor Vemurafenib Activates Mitochondrial Metabolism and Inhibits Hyperpolarized Pyruvate–Lactate Exchange in BRAF-Mutant Human Melanoma Cells

Teresa Delgado‐Goñi, Maria Falck Miniotis, Slawomir Wantuch, +5

Molecular Cancer Therapeutics

Increased inflammatory lipid metabolism and anaplerotic mitochondrial activation follow acquired resistance to vemurafenib in BRAF-mutant melanoma cells

Teresa Delgado‐Goñi, Teresa Casals Galobart, Slawomir Wantuch, +4

British Journal of Cancer

Lentiviral Hematopoietic Stem Cell Gene Therapy Rescues Clinical Phenotypes in a Murine Model of Pompe Disease

Giuseppa Piras, Claudia Montiel-Equihua, Yee-Ka Agnes Chan, +15

Molecular Therapy — Methods & Clinical Development

Identifying Division Symmetry of Mouse Embryonic Stem Cells: Negative Impact of DNA Methyltransferases on Symmetric Self-Renewal

Lukasz Jasnos, Fatma Betül Aksoy, Hersi Mohamed Hersi, +2

Stem Cell Reports

Detecting human melanoma cell re-differentiation following BRAF or heat shock protein 90 inhibition using photoacoustic and magnetic resonance imaging

Anant Shah, Teresa Delgado‐Goñi, Teresa Casals Galobart, +6

Scientific Reports